X-48904831-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005660.3(SLC35A2):​c.1078G>A​(p.Val360Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00016 in 1,209,892 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 87 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V360L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., 16 hem., cov: 24)
Exomes 𝑓: 0.00013 ( 0 hom. 71 hem. )

Consequence

SLC35A2
NM_005660.3 missense

Scores

14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.175

Publications

1 publications found
Variant links:
Genes affected
SLC35A2 (HGNC:11022): (solute carrier family 35 member A2) This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014]
SLC35A2 Gene-Disease associations (from GenCC):
  • SLC35A2-congenital disorder of glycosylation
    Inheritance: XL, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00741449).
BP6
Variant X-48904831-C-T is Benign according to our data. Variant chrX-48904831-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 509462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 16 XL,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC35A2NM_005660.3 linkc.1078G>A p.Val360Ile missense_variant Exon 4 of 5 ENST00000247138.11 NP_005651.1 P78381-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC35A2ENST00000247138.11 linkc.1078G>A p.Val360Ile missense_variant Exon 4 of 5 1 NM_005660.3 ENSP00000247138.5 P78381-1

Frequencies

GnomAD3 genomes
AF:
0.000455
AC:
51
AN:
112162
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00110
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000565
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000259
AC:
47
AN:
181333
AF XY:
0.000302
show subpopulations
Gnomad AFR exome
AF:
0.00139
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000247
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000130
AC:
143
AN:
1097675
Hom.:
0
Cov.:
31
AF XY:
0.000196
AC XY:
71
AN XY:
363053
show subpopulations
African (AFR)
AF:
0.00170
AC:
45
AN:
26393
American (AMR)
AF:
0.00
AC:
0
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19366
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30196
South Asian (SAS)
AF:
0.00154
AC:
83
AN:
54045
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4123
European-Non Finnish (NFE)
AF:
0.00000831
AC:
7
AN:
841858
Other (OTH)
AF:
0.000174
AC:
8
AN:
46072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000454
AC:
51
AN:
112217
Hom.:
0
Cov.:
24
AF XY:
0.000465
AC XY:
16
AN XY:
34399
show subpopulations
African (AFR)
AF:
0.00145
AC:
45
AN:
30945
American (AMR)
AF:
0.00
AC:
0
AN:
10638
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3546
South Asian (SAS)
AF:
0.00111
AC:
3
AN:
2707
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6166
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000565
AC:
3
AN:
53136
Other (OTH)
AF:
0.00
AC:
0
AN:
1530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000267
Hom.:
3
Bravo
AF:
0.000487
ESP6500AA
AF:
0.00287
AC:
11
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000354
AC:
43

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 22, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Dec 24, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC35A2: BP4, BS2 -

SLC35A2-congenital disorder of glycosylation Benign:1
Jan 16, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-1.0
CADD
Benign
5.3
DANN
Benign
0.86
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.45
T;T;T
M_CAP
Benign
0.0036
T
MetaRNN
Benign
0.0074
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.17
PROVEAN
Benign
-0.81
N;N;N
REVEL
Benign
0.042
Sift
Benign
0.46
T;T;T
Sift4G
Benign
0.19
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.13
MVP
0.043
ClinPred
0.0059
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.025
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138190020; hg19: chrX-48762108; API